Shares shifted as Viavi Solutions posted fiscal Q2 2026 results that blew past its own guidance, riding a wave of spending on AI data centers and defense networks. But with the stock now doubling off its January lows, investors must weigh explosive top-line growth against a balance sheet still carrying significant debt and a GAAP bottom line that remains in the red.

Data Center Demand Is Doing the Heavy Lifting

Viavi's network and service enablement segment grew roughly 46% year over year, driven primarily by demand from the data center ecosystem and aerospace and defense customers.

That demand came from high-performance chip makers and optical-module firms building out AI data centers , turning Viavi's niche testing tools into must-have equipment during an infrastructure boom. Management guided Q3 revenue of $386–$400 million , with non-GAAP operating margins expected to improve to 19.7% and EPS of $0.22–$0.24 — suggesting the momentum is not a one-quarter fluke.

The Profit Picture Has Two Very Different Versions

Non-GAAP operating margin hit 19.3%, above the high end of guidance, expanding 440 basis points year over year, and non-GAAP EPS of $0.22 beat the $0.18–$0.20 forecast. But the GAAP view is far uglier: GAAP operating profit fell nearly 49% and the company posted a $48.1 million net loss , weighed down by acquisition-related charges and restructuring costs. Investors betting on profitability must trust that non-GAAP adjustments eventually converge with reality.

The Balance Sheet Got a $500 Million Reset — With Strings

In May, Viavi sold 11.1 million shares at $45 apiece , netting approximately $484 million after fees.

Those proceeds are earmarked to repay a $450 million term loan , which will slash interest costs. The trade-off: dilution. Even post-offering, roughly $836 million in long-term debt remains against about $499 million in cash , and debt-to-equity still sits at 129%.

Index Promotion Adds a Short-Term Bid

Viavi was officially added to the S&P MidCap 400 on June 22, prompting a 12% single-day rebound as funds tracking the index were required to buy shares, increasing demand mechanically. That forced buying is a one-time catalyst, not a fundamental one — and the stock's slide from $52.94 back to $43.68 in a single session suggests the sugar rush is already fading.